Literature DB >> 10357078

Amphetamine dose dependently disrupts prepulse inhibition of the acoustic startle response in rats within a narrow time window.

T L Sills1.   

Abstract

Prepulse inhibition (PPI) of the acoustic startle response refers to the reduction in startle amplitude when a weak prepulse precedes a startle-inducing pulse. Prepulse inhibition has been shown to be disrupted by amphetamine at doses that also stimulate locomotor activity, and it has been suggested that the same neuroanatomical substrate, mesolimbic dopamine activation, mediates the effects of amphetamine on locomotor activity and PPI. Amphetamine stimulates locomotor activity and mesolimbic dopamine release over a 1- to 3-h period, whereas PPI is typically measured within the first 30 min following amphetamine treatment. The present study therefore determined whether delays in testing would alter the PPI-disruptive effect of amphetamine in male Wistar rats. Amphetamine dose dependently disrupted PPI when the test session occurred 10 min following amphetamine treatment and only when the prepulse intensity was 5-10 dB above background. Delays of 40 and 60 min post-amphetamine injection, however, resulted in a loss of the ability of amphetamine to disrupt PPI although locomotor activity was significantly stimulated by amphetamine at these time points. The data from the present study therefore do not readily fit with the notion that the effects of amphetamine on locomotion and PPI are mediated by the same substrate.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10357078     DOI: 10.1016/s0361-9230(99)00036-2

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  12 in total

1.  Effects of acute ethanol or amphetamine administration on the acoustic startle response and prepulse inhibition in adolescent and adult rats.

Authors:  Steven Craig Brunell; Linda Patia Spear
Journal:  Psychopharmacology (Berl)       Date:  2006-04-25       Impact factor: 4.530

2.  Developmental GABAergic deficit enhances methamphetamine-induced apoptosis.

Authors:  Tomohiro Abekawa; Koki Ito; Yasuya Nakato; Tsukasa Koyama
Journal:  Psychopharmacology (Berl)       Date:  2011-04-14       Impact factor: 4.530

3.  Ventral striatal noradrenergic mechanisms contribute to sensorimotor gating deficits induced by amphetamine.

Authors:  Karen M Alsene; Katie Fallace; Vaishali P Bakshi
Journal:  Neuropsychopharmacology       Date:  2010-08-04       Impact factor: 7.853

4.  PPI deficit induced by amphetamine is attenuated by the histamine H1 antagonist pyrilamine, but is exacerbated by the serotonin 5-HT2 antagonist ketanserin.

Authors:  José A Larrauri; Edward D Levin
Journal:  Psychopharmacology (Berl)       Date:  2010-09-02       Impact factor: 4.530

5.  The role of endogenous neurotensin in psychostimulant-induced disruption of prepulse inhibition and locomotion.

Authors:  Ricardo Cáceda; Elisabeth B Binder; Becky Kinkead; Charles B Nemeroff
Journal:  Schizophr Res       Date:  2011-11-21       Impact factor: 4.939

6.  The α₂-adrenergic antagonist idazoxan counteracts prepulse inhibition deficits caused by amphetamine or dizocilpine in rats.

Authors:  José A Larrauri; Edward D Levin
Journal:  Psychopharmacology (Berl)       Date:  2011-06-28       Impact factor: 4.530

7.  Prepulse inhibition during withdrawal from an escalating dosage schedule of amphetamine.

Authors:  Holger Russig; Carol A Murphy; Joram Feldon
Journal:  Psychopharmacology (Berl)       Date:  2002-11-12       Impact factor: 4.530

8.  Dopamine and nitric oxide interaction on the modulation of prepulse inhibition of the acoustic startle response in the Wistar rat.

Authors:  C Salum; F S Guimarães; M L Brandão; E A Del Bel
Journal:  Psychopharmacology (Berl)       Date:  2006-01-10       Impact factor: 4.530

Review 9.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

10.  Central administration of p-hydroxyamphetamine produces a behavioral stimulant effect in rodents: evidence for the involvement of dopaminergic systems.

Authors:  Hiroshi Onogi; Masato Hozumi; Osamu Nakagawasai; Yuichiro Arai; Seiichiro Ishigaki; Atsushi Sato; Seiichi Furuta; Fukie Niijima; Koichi Tan-No; Takeshi Tadano
Journal:  Psychopharmacology (Berl)       Date:  2009-12-04       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.